Merck Introduces Aptegra CHO genetic stability assay for accelerated biosafety testing

Post author:
Post published:April 23, 2024
Post category:uncategorized

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

UCLA study reveals key signs for genetic testing in neurodevelopment disorders

Georgia’s Medicaid work requirements costing taxpayers millions despite low enrollment

Large-scale study presents findings on implications of plant vs animal ultra-processed foods on cardiovascular disease risk

Helpful Links

Subscribe To Us